Navigation Links
Watson Confirms OxyContin® Patent Challenge
Date:3/25/2011

armaceutical company.  The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release.  It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors, risks and uncertainties affecting Watson's business. These factors include, among others, the difficulty of predicting the timing and outcome of the pending patent litigation; the difficulty of predicting the timing or outcome of product development efforts, including FDA and other regulatory agency approvals and actions, if any; the impact of competitive products and pricing; the timing and success of product launches; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson and its third party manufacturers' facilities, products and/or businesses; changes in the laws and regulations, including Medicare and Medicaid, affecting among other things, pricing and reimbursement of pharmaceutical products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's annual report on For
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... FRANCISCO , July 2, 2015  The Green ... ), the world,s first HIPAA compliant mobile app that ... of farm-to-table fresh medical marijuana, announced today that their ... Unlike Eaze, Meadow and more than half a ... the last year, Loud Cannabis is unique in that ...
(Date:7/2/2015)... 2, 2015   Decision Resources Group ... identify less frequent dosing as the highest unmet ... the burden on both patients and providers associated ... (VEGF) injections, which are the current standard of ... which is in development for dosing every two ...
(Date:7/2/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Emerging Technologies, Competitive Landscape" report to ... in Clinical Chemistry and Immunodiagnostics: Global Challenges, ... seven-country strategic analysis of major business opportunities ...
Breaking Medicine Technology:New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
(Date:7/2/2015)... ... July 02, 2015 , ... ... M.D., to the orthopedic and spine surgery team at their Anaheim clinic. Dr. ... and tendonitis. Along with the spine and spine surgery, Dr. Krishnareddy also specializes ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... Real Time Pain Relief (RTPR), ... an agreement with Big Sky PBR to sponsor The Fifth Annual Big Sky ... Pain Relief will offer product samples of their popular pain relief lotion and products at ...
(Date:7/2/2015)... ... July 02, 2015 , ... Scientists ... received nearly $4 million through five federal grants to study a group of ... the deadly diseases. , The research will be conducted in the Regional ...
(Date:7/2/2015)... OR (PRWEB) , ... July 02, 2015 , ... Hand ... During the current summer flu season, according to fresh water advocate and radio host ... on the hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied ...
(Date:7/2/2015)... ... July 02, 2015 , ... After conducting a nationwide executive ... Medical Center in Yuma, Ariz., has hired Robert Trenschel, DO, as chief executive ... management, Dr. Trenschel will assume his new duties at Yuma Regional Medical Center on ...
Breaking Medicine News(10 mins):Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3
... News) -- Among certain patients with a history of ... (dabigatran) appears to be as effective as the anticoagulant ... research reveals. Specifically, the new study suggests that ... as effectively as warfarin among those facing an elevated ...
... cancer patients are more likely to have joint pain from ... according to a study presented at the American College of ... is one of the first to identify factors that increase ... AI therapy. AIs, the standard adjuvant therapy for post-menopausal ...
... how an amphibious fish stays alive for up to two months ... small fishonly about an inch or two longthat live in temporary ... and Florida. During dry seasons when their pools disappear, the fish ... they stay moist, they can survive for extended periods out of ...
... Serena Gordon HealthDay Reporter , SUNDAY, Nov. 7 ... more than the joints, new research suggests. The ... buildup of plaque in the blood vessels, potentially increasing the ... The good news from the study is that certain drugs ...
... treating children with night-time cough and congestion and improves ... State College of Medicine researchers. , "Upper respiratory infections ... said Ian Paul, M.D., M.Sc., associate professor of pediatrics ... are disruptive for children, and often disturb sleep for ...
... HILL, N.C. In the largest study to date ... improvement in pain, fatigue, stiffness and sense of well-being. ... improved, said Leigh Callahan, PhD, the study,s lead author, ... Chapel Hill School of Medicine and a member of ...
Cached Medicine News:Health News:New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients 2Health News:New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients 3Health News:Study sheds light on aromatase inhibitor joint pain syndrome 2Health News:Study sheds light on aromatase inhibitor joint pain syndrome 3Health News:Special skin keeps fish species alive on land 2Health News:Rheumatoid Arthritis May Raise Risk of Blood Vessel Plaque 2Health News:Rheumatoid Arthritis May Raise Risk of Blood Vessel Plaque 3Health News:Vapor rub relieves cold symptoms for children, helps them sleep better 2Health News:Vapor rub relieves cold symptoms for children, helps them sleep better 3Health News:Study: Tai Chi relieves arthritis pain, improves reach, balance, well-being 2
This flexiable metal clip-on easily attaches to most frames and allows for excellent radiation protection. Not available with side shields or in prescription....
... of extremely durable nylon that exhibits superior ... molded wrap around feature provides maximum comfort ... weight evenly over the nose while providing ... shields. Also available with adjustable nose ...
... optical steel base metal ... with custom fitted lead ... a seal to the ... scatter radiation protection. Includes ...
... steel base metal with bronze ... custom fitted 0.50mm leaded side ... to the front lenses for ... exposure. Includes adjustable non-slip silicon ...
Medicine Products: